fda glp-1 crackdown news The is cracking down on ‘misleading’ compounded GLP-1s from telehealth companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, FDA to Restrict Ingredients Used

If you notice eye problems, contact both your eye doctor and diabetes doctor right away so they can evaluate the situation together

The gluco- and liporegulatory and vasodilatory effects of glucose-dependent insulinotropic polypeptide (GIP) are abolished by an antagonist of the human GIP receptor

However, there are lifestyle-related impacts to glutathione IV therapy that makes it less preferable for some patient populations who can benefit most from the compound, which makes it less convenient than alternatives like oral supplementation

A Class III recall is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences